but not for ACE inhibitor dosage. Ten percent of the study patients developed severe hyperkalemia (≥6.0 meq/mL). The OR for the development of severe hyperkalemia was 3.36 for each progressive ...
Hyperkalemia occurred in three patients in the ramipril and one patient in the metoprolol randomization group. Ramipril was the only ACE inhibitor employed in the AASK study and angiotensin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback